| For: | Sohail A, Ali H, Patel P, Subramanium S, Dahiya DS, Sohail AH, Gangwani MK, Satapathy SK. Impact of metabolic dysfunction-associated steatotic liver disease on COVID-19 hospitalizations: A propensity-matched analysis of the United States. World J Virol 2024; 13(1): 91149 [PMID: 38616849 DOI: 10.5501/wjv.v13.i1.91149] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i1/91149.htm |
| Number | Citing Articles |
| 1 |
Marija Zdravkovic, Viseslav Popadic, Maja Popovic, Marija Brankovic, Milica Brajkovic, Jelica Bjekic-Macut, Tamara Trumpic, Branislava Daskalovic and
Planinka Zafirovska. Long COVID - From Pathophysiology to Rehabilitation. Public Health 2026; 16 doi: 10.5772/intechopen.1015784
|
| 2 |
Yunqi Zhang, Qingqing Xun, Shuyu Liu, Bo Zhuang, Meiyue Zang, Chengwei Tan, Yu Cui, Ruiji Li, Qianqian Zhang. Microbial exposure and host responses to infection reshape the disease trajectory of MASLD. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1932870
|
| 3 |
Miguel Jiménez‑Luevano, Ana Jiménez‑Partida, Miguel Jiménez‑Partida, Rodrigo Del Rio‑Hidalgo, Alejandro Bravo‑Hernández, María Villaseñor‑García, Alejandro Bravo‑Cuellar, Georgina Hernández‑Flores. Pentoxifylline in patients with COVID‑19 and with liver cirrhosis or metabolic dysfunction‑associated steatotic liver disease: Emerging insights. Biomedical Reports 2026; 24(6) doi: 10.3892/br.2026.2150
|